Journal
JOURNAL OF GENERAL VIROLOGY
Volume 95, Issue -, Pages 466-471Publisher
SOC GENERAL MICROBIOLOGY
DOI: 10.1099/vir.0.058495-0
Keywords
-
Categories
Funding
- National Health and Medical Research Council [APP1023141]
- Australian Research Council [FT110100310]
- Australian Research Council [FT110100310] Funding Source: Australian Research Council
Ask authors/readers for more resources
Modified vaccinia virus Ankara (MVA) is a candidate vaccine vector that is severely attenuated due to mutations acquired during several hundred rounds of serial passage in vitro. A previous study used marker rescue to produce a set of MVA recombinants with improved replication on mammalian cells. Here, we extended the characterization of these rescued MVA strains and identified vaccinia virus (VACV) gene F5L as a determinant of plaque morphology but not replication in vitro. F5 joins a growing group of VACV proteins that influence plaque formation more strongly than virus replication and which are disrupted in MVA. These defective genes in MVA confound the interpretation of marker rescue experiments designed to map mutations responsible for the attenuation of this important VACV strain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available